# Atomoxetine, Placebo and Parent Management Training in Autism

> **NCT00844753** · PHASE4 · COMPLETED · sponsor: **University of Rochester** · enrollment: 128 (actual)

## Conditions studied

- Autism
- Pervasive Development Disorder
- Asperger's Disorder
- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** atomoxetine
- **DRUG:** Placebo
- **BEHAVIORAL:** Parent Management Training

## Key facts

- **NCT ID:** NCT00844753
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2016-02-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00844753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00844753, "Atomoxetine, Placebo and Parent Management Training in Autism". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00844753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*